Last updated: August 27, 2024
Sponsor: HITEC-Institute of Medical Sciences
Overall Status: Active - Recruiting
Phase
N/A
Condition
Rash
Scalp Disorders
Acne
Treatment
Azithromycin 250 milligram Oral Capsule
D Max Drops
Adapalene
Clinical Study ID
NCT06141330
Vit-D
Ages 13-40 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Individuals aged between 13 and 40 years with diagnoses of Acne vulgaris areincluded.
Exclusion
Exclusion Criteria:
Individuals currently undergoing treatment for polycystic ovary syndrome (PCOs)
Those with obesity
Individuals employing vitamin supplementation
Those under the influence of topical or systemic steroids and acne treatment in thelast 2 months.
Study Design
Total Participants: 58
Treatment Group(s): 3
Primary Treatment: Azithromycin 250 milligram Oral Capsule
Phase:
Study Start date:
February 24, 2024
Estimated Completion Date:
October 31, 2024
Connect with a study center
Hitec-Ims
Islamabad, Punjab 47080
PakistanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.